SCHEMBL19222240

SCHEMBL19222240

CCCC(C(N)=O)N1Cc2c(O)cccc2C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ CRBN Q96SW2 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SLC6A2 P23975 2/20 0.34
▸ SLC6A3 Q01959 2/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA3 P07451 1/20 0.34
▸ CA4 P22748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17343919 0.89 ALOX15 (0.37) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL25907886 0.89 ALOX15 (0.37) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL20425363 0.88 KDM4E (0.45) ALOX15KDM4ECRBNALDH1A1POLB
SCHEMBL2257304 0.88 KDM4E (0.45) ALOX15KDM4ECRBNALDH1A1POLB
SCHEMBL17347665 0.86 MEN1 (0.36) KDM4ELMNAALDH1A1MAPTNPC1
SCHEMBL19222203 0.86 NPC1 (0.38) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL2251395 0.86 NPC1 (0.40) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL2248688 0.86 NPC1 (0.40) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL29471925 0.86 NPC1 (0.40) ALOX15KDM4ELMNACRBNALDH1A1
SCHEMBL29388571 0.86 NPC1 (0.40) ALOX15KDM4ELMNACRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289838-A2 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Celgene Corporation (US) 2023-12-13 — — EP disclosed
EP-3145513-B1 3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS CELGENE CORP (US) 2023-11-15 — — EP disclosed
EP-3599236-B1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2023-08-23 — — EP disclosed
WO-2022072576-A1 METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES CELGENE CORPORATION (US) 2022-04-07 — — WO disclosed
EP-3896062-A1 ISOINDOLINE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION OF ISOINDOLINE COMPOUND Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2021-10-20 — — EP disclosed
EP-3741372-A1 (S)-3-[4-(4-MORPHLIN-4-YLMETHYLBENZYLOXY)-1- OXO-1,3-DIHYDRO-ISOINDO-2-YL]PIPERIDINE-2,6-DIONE FOR USE IN THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES Celgene Corporation (US) 2020-11-25 — — EP disclosed
EP-2882441-B1 TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES CELGENE CORP (US) 2020-04-29 — — EP disclosed
EP-3599236-A1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Celgene Corporation (US) 2020-01-29 — — EP disclosed
EP-3202460-B1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2019-06-12 — — EP disclosed
EP-3106460-B1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2019-04-10 — — EP disclosed
WO-2019040109-A1 PROCESSES FOR PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE CELGENE CORPORATION (US) 2019-02-28 — — WO disclosed
EP-3202461-A1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Celgene Corporation (US) 2017-08-09 — — EP disclosed
EP-3202460-A1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Celgene Corporation (US) 2017-08-09 — — EP disclosed
Send feedback